Vijay Gayam to Sustained Virologic Response
This is a "connection" page, showing publications Vijay Gayam has written about Sustained Virologic Response.
Connection Strength
0.695
-
Outcomes of Direct-Acting Antiviral Treatment of Psychiatric Patients with Comorbid Hepatitis C Virus Infection. Dig Dis. 2020; 38(3):232-239.
Score: 0.171
-
Real-world study of hepatitis C treatment with direct-acting antivirals in patients with drug abuse and opioid agonist therapy. Scand J Gastroenterol. 2019 May; 54(5):646-655.
Score: 0.167
-
Real-World Clinical Efficacy and Tolerability of Direct-Acting Antivirals in Hepatitis C Monoinfection Compared to Hepatitis C/Human Immunodeficiency Virus Coinfection in a Community Care Setting. Gut Liver. 2018 11 15; 12(6):694-703.
Score: 0.161
-
Sofosbuvir based regimens in the treatment of chronic hepatitis C genotype 1 infection in African-American patients: a community-based retrospective cohort study. Eur J Gastroenterol Hepatol. 2018 10; 30(10):1200-1207.
Score: 0.160
-
Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis C. Eur J Gastroenterol Hepatol. 2017 Jul; 29(7):767-776.
Score: 0.037